NEO

#2405
NeoGenomics, Inc.
8.35 USD
+4.37%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
8.35
8.35
년간 변동
4.72
13.74
일일 변동
+4.37%
월간 변동
+3.99%
6달 변화
-12.11%
년간 변동율
-13.20%
이전 종가
8.00
Open
8.35
Bid
Ask
Low
8.35
High
8.35
양
75
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 1.08 B
  • Employee 2 500
  • Founded 2002
  • CEO Christopher M. Smith
  • Website www.neogenomics.com
  • Headquarter Nevada, United States
  • FIGI BBG000BKH263
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-14
Price to sales ratio
2.07

NeoGenomics Inc

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

뉴스